Compare CABR & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CABR | TRIB |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2M | 18.6M |
| IPO Year | N/A | N/A |
| Metric | CABR | TRIB |
|---|---|---|
| Price | $0.90 | $0.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 181.2K | ★ 9.3M |
| Earning Date | 03-20-2026 | 02-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,493.00 | ★ $49,409,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.06 | $0.48 |
| 52 Week High | $6.00 | $3.44 |
| Indicator | CABR | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.83 |
| Support Level | N/A | $0.80 |
| Resistance Level | N/A | $1.75 |
| Average True Range (ATR) | 0.00 | 0.17 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 3.15 |
Caring Brands Inc is a consumer wellness company specializing in over-the-counter (OTC) and cosmetic products.support health and wellness through the research and development of over-the-counter (OTC) products and intellectual property. It product pipeline addresses a range of conditions, including hair loss, eczema, burns, and sexual wellness. Company's majority of revenue is generated through the sales of OTC and consumer products and licensing royalties.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.